Skip to main content

Advertisement

Table 1 Relationships between protein tyrosine kinase 6 (PTK6) expression level and clinicopathologic characteristics of the patients with early-stage squamous cervical cell cancer

From: The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer

Characteristic Total (cases) PTK6 expression [cases (%)] χ2 value P value
High Low
Age (years)     0.172 0.679
 ≤45 81 36 (44.4) 45 (55.6)   
 >45 69 33 (47.8) 36 (52.2)   
Tumor size (cm)     0.842 0.359
 ≤4 138 65 (47.1) 73 (52.9)   
 >4 12 4 (33.3) 8 (66.7)   
Tumor grade     7.651 0.020*
 1 6 6 (100) 0 (0)   
 2 38 18 (47.4) 20 (52.6)   
 3 106 45 (42.5) 61 (57.5)   
Clinical stage     3.484 0.323
 IB1 99 45 (45.5) 54 (54.5)   
 IB2 12 4 (33.3) 8 (66.7)   
 IIA1 34 19 (55.9) 15 (44.1)   
 IIB 5 1 (20.0) 4 (80.0)   
Pelvic lymph node metastasis     0.176 0.675
 Absent 109 49 (45.0) 60 (55.0)   
 Present 41 20 (48.8) 21 (51.2)   
Deep cervical stromal invasion     2.028 0.154
 Absent 71 37 (52.1) 34 (47.9)   
 Present 79 32 (40.5) 47 (59.5)   
SCC antigen level (ng/mL)     3.671 0.055
 ≤1.5 99 40 (40.4) 59 (59.6)   
 >1.5 51 29 (56.9) 22 (43.1)   
Lymphovascular space invasion     0.115 0.734
 Absent 134 61 (45.5) 73 (54.5)   
 Present 16 8 (50.0) 8 (50.0)   
  1. SCC squamous cell carcinoma
  2. * The P value was obtained with the Fisher exact test